Since its founding in 2003, Neopharma has emerged as a global, technologically driven and innovation-oriented company. Neopharma’s global presence is supported by 10 manufacturing facilities spread across 3 continents and regional offices in 50+ countries. Delivering branded and generic formulations and active pharmaceutical ingredients (API’s). Our vision is to create a comprehensive ‘integrated healthcare enterprise’ which shall innovate and adapt to deliver the best in healthcare by never compromising on our values of commitment, excellence, innovation and integrity.
Neopharma and GSK Partnership Produces First Line of Medicines Packaged in UAE8 January 2020 Read More
Neopharma forms JV with Elevar Therapeutics for Commercialization of Oncology NCE3 October 2019 Read More